Cytomegalovirus Vaccine
Passive immunization decreases risk of congenital cytomegalovirus
Published in Vaccine Weekly, November 23rd, 2005
According to recent research published in the New England Journal of Medicine, "Currently, there is no effective intervention for a primary cytomegalovirus (CMV) infection during pregnancy. We studied pregnant women with a primary CMV infection. The therapy group comprised women whose amniotic fluid contained either CMV or CMV DNA and who were offered intravenous CMV hyperimmune globulin at a dose of 200 U/kg maternal weight. A prevention group, consisting of women with a recent primary infection before 21 weeks' gestation or who declined amniocentesis, was offered...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-11-23)
More Articles from Vaccine Weekly
- Alzheimer Disease Vaccine
Adenovirus vector induced an anti-inflammatory immune response - Anthrax Vaccine Development
Nonhuman primate adenovirus-based vaccine protected against anthrax toxin - Coccidioidomycosis Vaccine
Dendritic cell vaccine protects mice against Coccidioides posadasii - Malaria Vaccine
Three Plasmodium proteins show promise as combination vaccine - Rotavirus Vaccine
Attenuated rotavirus vaccine protects against rotavirus infection - Alzheimer Disease Vaccine
Aldolase is target antigen in Alzheimer disease - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
